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Dear Editor,
Genome-wide association studies (GWAS) provide evidence
for a potentially large polygenic component in schizophrenia
risk (Purcell et al. 2009), andmeta-analyses of polymorphisms
have recently been used in the attempt to identify true candi-
date genes (Allen et al. 2008). One gene identified as a
susceptibility candidate by linkage analysis is PIP4K2A , cod-
ing for the phosphatidylinositol 5-phosphate 4-kinase,
PI5P4Kα (Bakker et al. 2007; Schwab et al. 2006).
Although GWAS and meta-analysis have not confirmed
PIP4K2A as contributory to disease risk, the contradictory
association studies listed on the SzGene database (Allen et al.
2008) may indicate genetic or phenotypic heterogeneity in an
allelic variant of small effect size (Schwab and Wildenauer
2009). Although multiple DNA sequence variants have been
reported for PIP4K2A , only one non-synonymous SNP in the
coding region has been identified (rs10828317), causing an
allelic change of asparagine to serine (N251S). This gene
variant was found to be significantly associated with schizo-
phrenia in two separate case studies (Bakker et al. 2007;
Schwab et al. 2006).
PI5P4Kα is one of the three isoforms present in mammalian
cells that convert the membrane lipid phosphatidylinositol 5-
phosphate (PI5P) to phosphatidylinositol 4,5-bisphosphate
(PI(4,5)P2). The main route for PI(4,5)P2 synthesis in the cell
is the conversion of the alternative substrate, phos-
phatidylinositol 4-phosphate (PI4P), by the phos-
phatidylinositol 4-phosphate 5-kinases (Di Paolo and De
Camilli 2006). Consistent with substrate abundance in cells
(in a typical cell relative PI5P levels are approximately 2 % of
PI4P levels), the minor contribution of the conversion of PI5P
to PI(4,5)P2 suggests that the PI5P4Ks function to attenuate a
signalling role of PI5P itself or to generate a localised
(compartmentalised) pool of the PI(4,5)P2 second messenger
molecule (Clarke et al. 2007).
Phosphoinositides have been shown to regulate a number of
different channels and transporters, and recent evidence pub-
lished in this journal suggests that the schizophrenia-associated
PI5P4Kα N251S variant may be involved indirectly in modu-
lating neuronal excitability. PIP2 regulates neuronal KCNQ
potassium channels, which determine membrane potential sen-
sitive to muscarinic receptor signalling (M current). This sup-
presses activity of dopaminergic neurons, and a recent study
links PI5P4Kα N251S to this (Fedorenko et al. 2008). The
PI5P4Kα variant has also been shown to be involved with the
decreased glutamate uptake by the excitatory amino acid trans-
porter, EEAT3, and the altered glutamate metabolism induced
by EEAT3 has also been implicated in schizophrenia
(Fedorenko et al. 2009). These studies suggested that the activ-
ity of PI5P4KαN251S might be impaired in comparison to the
wild-type enzyme, although no direct enzymic measurements
have yet been made. Earlier studies also noted that functional
activity measurements of the PI5P4K schizophrenia variant
were required (Schwab et al. 2006).
Here, we report on the relative intrinsic activities of the
PI5P4Kα protein variants. Human PIP4K2A was cloned into
a bacterial expression vector (PI5P4Kα WT). Site-directed
mutagenesis was performed to make a base change in codon
251 (AAC to AGC), recreating the sequence for the allelic
SNP (PI5P4Kα N251S). Site-directed mutagenesis was also
used to produce a kinase-dead version of PI5P4Kα (D273K).
Full-length protein from all forms was purified by proteolytic
cleavage from the expressed affinity tag.
To determine whether the N251S variant was a catalytically
disabled enzyme, the ATPase activity of the kinase was tested.
This monitors the ability of the enzyme to bind and utilise
ATP in the absence of lipid substrate as intrinsic futile cycling.
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ATP utilisation was assayed using the Transcreener ADP2
fluorescence polarisation method for a range of enzyme con-
centrations and the relationship plotted using nonlinear regres-
sion analysis, as depicted in Fig. 1a. In comparison to the
kinase-dead mutant, both the wild-type and N251S PI5P4Kα
variants showed appreciable ability to process ATP, indicating
that both are functional kinases.
Lipid kinase activity was assessed by incubation of purified
protein with PI5P micelles in the presence of [γ-32P]ATP, as
described previously (Clarke et al. 2001). Radiolabelled lipid
product (PI(4,5)P2) was extracted by acidic phase separation
and isolated by thin-layer chromatography. Counts from these
radioactive lipid spots were converted to specific activity units
using integral plate controls. Figure 1b shows the comparative
activity of wild-type PI5P4Kα against the negative control
kinase-dead mutant. The difference in observed activity be-
tween PI5P4KαWTand PI5P4Kα N251S was not statistical-
ly different using an unpaired t test.
These data suggest that PI5P4Kα N251S does not signif-
icantly differ in activity from the wild-type enzyme.
Furthermore, alignment of the PI5P4K isoform sequences
show that the corresponding amino acid in the PI5P4Kβ
sequence is also a serine, and this isoform is still active
(Fig. 1b).
A recent observation suggesting that PI5P4Kα may be
upregulated (based on mRNA levels) in non-neuronal cells
of schizophrenia patients (Saggers-Gray et al. 2011) implies
that the enzyme titre or localisation may be more relevant than
the activity. So rather than a consequence of impaired PI5P4K
activity, the PI5P4Kα N251S variant may be impaired in its
ability to directly associate with ion channels or to regulate the
trafficking of the channels to the plasma membrane. Indeed, a
defect in such trafficking associated with the N251S mutation
was experimentally demonstrated by Fedorenko et al. (2009).
Thus our observation of unimpaired activity of PI5P4Kα
N251S throws a new light on its association with schizophre-
nia, which warrants further mechanistic investigation.
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